关注
elizaveta fasler-kan
elizaveta fasler-kan
forschungsleiterin
在 insel.ch 的电子邮件经过验证
标题
引用次数
引用次数
年份
Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy …
S Zuklys, G Balciunaite, A Agarwal, E Fasler-Kan, E Palmer, ...
The Journal of Immunology 165 (4), 1976-1983, 2000
3312000
Circulating microparticles: square the circle
NS Barteneva, E Fasler-Kan, M Bernimoulin, JNH Stern, ED Ponomarev, ...
BMC cell biology 14, 1-21, 2013
3102013
Imaging flow cytometry: coping with heterogeneity in biological systems
NS Barteneva, E Fasler-Kan, IA Vorobjev
Journal of Histochemistry & Cytochemistry 60 (10), 723-733, 2012
2672012
The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells
IG Silva, IM Yasinska, SS Sakhnevych, W Fiedler, J Wellbrock, M Bardelli, ...
EBioMedicine 22, 44-57, 2017
2242017
The Tim-3-Galectin-9 pathway and its regulatory mechanisms in human breast cancer
IM Yasinska, SS Sakhnevych, L Pavlova, A Teo Hansen Selnø, ...
Frontiers in immunology 10, 1594, 2019
1702019
Defective Jak‐STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon‐α
A Pansky, P Hildebrand, E Fasler‐Kan, L Baselgia, S Ketterer, ...
International journal of cancer 85 (5), 720-725, 2000
1422000
Interferon‐α activates signal transducers and activators of transcription 5 and 6 in Daudi cells
E Fasler‐Kan, A Pansky, M Wiederkehr, M Battegay, MH Heim
European journal of biochemistry 254 (3), 514-519, 1998
951998
Ligand-receptor interactions of galectin-9 and VISTA suppress human T lymphocyte cytotoxic activity
IM Yasinska, NH Meyer, S Schlichtner, R Hussain, G Siligardi, ...
Frontiers in immunology 11, 580557, 2020
782020
The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
I Gonçalves Silva, L Rüegg, BF Gibbs, M Bardelli, A Fruehwirth, L Varani, ...
Oncoimmunology 5 (7), e1195535, 2016
762016
Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease
I Mecklenburg, D Reznik, E Fasler-Kan, J Drewe, C Beglinger, P Hruz, ...
Journal of Crohn's and Colitis 8 (11), 1392-1397, 2014
692014
The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells
A Prokhorov, BF Gibbs, M Bardelli, L Rüegg, E Fasler-Kan, L Varani, ...
The international journal of biochemistry & cell biology 59, 11-20, 2015
672015
Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma
A Pansky, A DE WEERTH, E Fasler-Kan, JL Boulay, M Schulz, S Ketterer, ...
Journal of the American Society of Nephrology 11 (8), 1409-1418, 2000
642000
Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-κB and reduces myocardial infarct size in rats
S Meili-Butz, T Niermann, E Fasler-Kan, V Barbosa, N Butz, D John, ...
European journal of pharmacology 586 (1-3), 251-258, 2008
632008
Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of Kingdoms
NS Barteneva, Y Baiken, E Fasler-Kan, K Alibek, S Wang, N Maltsev, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (2), 372-393, 2017
522017
High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression
IM Yasinska, I Gonçalves Silva, SS Sakhnevych, L Ruegg, R Hussain, ...
Oncoimmunology 7 (6), e1438109, 2018
462018
Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3
E Fasler-Kan, C Suenderhauf, N Barteneva, B Poller, D Gygax, J Huwyler
Brain research 1354, 15-22, 2010
402010
Cell sorting in cancer research—diminishing degree of cell heterogeneity
NS Barteneva, K Ketman, E Fasler-Kan, D Potashnikova, IA Vorobjev
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (1), 105-122, 2013
382013
Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 …
ATH Selnø, S Schlichtner, IM Yasinska, SS Sakhnevych, W Fiedler, ...
Aging (Albany NY) 12 (23), 23478, 2020
352020
Activated STAT3 in choroidal neovascular membranes of patients with age-related macular degeneration
E Fasler-Kan, K Wunderlich, P Hildebrand, J Flammer, P Meyer
Ophthalmologica 219 (4), 214-221, 2005
342005
On prilled nanotubes-in-microgel oral systems for protein delivery
JK de Kruif, G Ledergerber, C Garofalo, E Fasler-Kan, M Kuentz
European Journal of Pharmaceutics and Biopharmaceutics 101, 90-102, 2016
322016
系统目前无法执行此操作,请稍后再试。
文章 1–20